Literature DB >> 7814615

A cholesterol deficiency syndrome in humans.

W E Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814615      PMCID: PMC295355          DOI: 10.1172/JCI117639

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

Authors:  D W SMITH; L LEMLI; J M OPITZ
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

Review 2.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans.

Authors:  J M Dietschy; S D Turley; D K Spady
Journal:  J Lipid Res       Date:  1993-10       Impact factor: 5.922

3.  Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.

Authors:  G Xu; G Salen; S Shefer; G C Ness; T S Chen; Z Zhao; G S Tint
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

4.  Cholesterol metabolism and placental transfer in the pregnant Rhesus monkey.

Authors:  R M Pitkin; W E Connor; D S Lin
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

5.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.

Authors:  G S Tint; M Irons; E R Elias; A K Batta; R Frieden; T S Chen; G Salen
Journal:  N Engl J Med       Date:  1994-01-13       Impact factor: 91.245

  5 in total
  1 in total

1.  Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.

Authors:  S Shefer; G Salen; A K Batta; A Honda; G S Tint; M Irons; E R Elias; T C Chen; M F Holick
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.